ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0035

Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA

Daniele Marcy1, Ashley Visser2, Claudia Lugo2, Kristin Sturm2 and Kristen Demoruelle3, 1University of Colorado Anschutz Medical Campus, Northglenn, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Golden, CO

Meeting: ACR Convergence 2024

Keywords: Anti-CCP, pregnancy, rheumatoid arthritis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: It is well established that women develop RA approximately three times more often than men. In addition, several risk factors for RA uniquely effect women, including the postpartum period. In the first year following childbirth, studies demonstrate an approximate 6-fold increase in RA incidence compared to age matched women who have not recently given birth. The exact mechanism by which the postpartum period contributes to RA pathogenesis is unknown. Our group has previously found that anti-cyclic citrullinated peptide (CCP) antibodies can be generated in the female genital tract mucosa in association with local inflammation in women without RA. Herein, we aimed to establish the relationship between anti-CCP generation at this female-specific mucosal site and the postpartum period.

Methods: We included 26 serum anti-CCP negative women without RA who had delivered a baby in the preceding 12 months and 26 serum anti-CCP negative premenopausal female controls matched on age, sex, smoking and contraceptive method use. All women self-collected a cervicovaginal fluid (CVF) sample with an aspirator or menstrual cup. CVF was processed with PBS, mechanical syringe-based homogenization, and centrifugation to obtain the cell-free supernatant. CVF supernatant was tested for anti-CCP-IgG (CCP3 ELISA, Werfen). Notably, IgG is the predominant antibody isotype of the vaginal mucosa and not IgA, like some other mucosal sites. CVF anti-CCP levels were compared between groups by Wilcoxon signed rank test and linear regression models.

Results: CVF anti-CCP-IgG levels were higher in postpartum women compared to matched controls (Figure 1). Postpartum women were more likely to have ever been pregnant compared to controls (Table 1), and higher CVF anti-CCP-IgG levels remained significantly associated with postpartum women after accounting for ever pregnancy in multivariable models (p=0.03). Within postpartum women, there was no significant relationship between CVF anti-CCP-IgG levels and age, smoking, current contraceptive method, months since delivery, type of delivery, or pregnancy associated complication (Table 2).

Conclusion: Anti-CCP-IgG levels are increased in the female genital tract mucosa in women without RA who were in the first year postpartum. Absence of serum anti-CCP in these women suggests local mucosal antibody generation. Additional studies are needed to understand the mechanisms by which childbirth can lead to anti-CCP generation in the female genital tract mucosa as well as whether inflammation and anti-CCP generation in the female genital tract could help to explain why the incidence of RA is increased during the postpartum period in premenopausal women.

Supporting image 1

Figure 1. CVF anti-CCP-IgG levels in postpartum women and matched controls. All women were serum anti-CCP negative. P-value calculated by Wilcoxon signed rank test.

Supporting image 2

Supporting image 3


Disclosures: D. Marcy: None; A. Visser: None; C. Lugo: None; K. Sturm: None; K. Demoruelle: Boehringer-Ingelheim, 5, Gilead, 5, Pfizer, 5.

To cite this abstract in AMA style:

Marcy D, Visser A, Lugo C, Sturm K, Demoruelle K. Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/anti-ccp-generation-in-the-female-genital-tract-is-increased-during-the-postpartum-period-in-women-without-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-ccp-generation-in-the-female-genital-tract-is-increased-during-the-postpartum-period-in-women-without-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology